Abstract
Breast cancer is the most prevalent tumor type among females and has a unique complexity, with considerable heterogeneity. Breast tumors can be classified into molecular subgroups to better target the therapeutic choice. However, even among patients of the same group there is a wide range of prognostic and therapeutic behavior, demonstrating a real need to identify more precise biomarkers…